Bilateral Diffuse Uveal Melanocytic Proliferation: Risks & Signs

Written by Medicover Team and Medically Reviewed by Dr Manaswini Priya Varanasi , Ophthalmologists



Bilateral Diffuse Uveal Melanocytic Proliferation (BDUMP) is a rare paraneoplastic syndrome in which benign melanocytic cells within the uveal tract of both eyes grow abnormally. It is usually associated with an underlying systemic cancer, most commonly cancers of the ovary, uterus, lung, pancreas, or gastrointestinal tract. The condition causes progressive vision loss due to changes in the retina, retinal pigment epithelium, and uveal tissues. Early recognition of BDUMP is important because it may be the first sign of an undiagnosed malignancy.


What Are the Types of Bilateral Diffuse Uveal Melanocytic Proliferation (BDUMP)?

BDUMP is considered a single clinical entity rather than a disorder with distinct subtypes. However, it may be categorized based on the associated underlying cancer.

  • Gynecologic cancer-associated BDUMP: Occurs with ovarian, uterine, or cervical cancers and is more common in women.
  • Lung cancer-associated BDUMP: Develops in patients with primary lung malignancies.
  • Gastrointestinal cancer-associated BDUMP: Associated with cancers of the stomach, pancreas, colon, or other digestive organs.
  • Other malignancy-associated BDUMP: May occur with breast cancer, prostate cancer, bladder cancer, or other solid tumors.

What Are the Symptoms of Bilateral Diffuse Uveal Melanocytic Proliferation (BDUMP)?

Symptoms usually affect both eyes and gradually worsen over time. Vision loss is often progressive and may develop before the underlying cancer is diagnosed.

  • Progressive blurred vision in both eyes.
  • Reduced visual acuity.
  • Distorted vision (metamorphopsia).
  • Dark spots or blind spots in the visual field.
  • Increased sensitivity to light (photophobia).
  • Difficulty reading or recognizing faces.
  • Rapidly developing cataracts in some patients.
  • Progressive vision loss that may lead to severe visual impairment if untreated.

What Are the Causes of Bilateral Diffuse Uveal Melanocytic Proliferation (BDUMP)?

BDUMP is a paraneoplastic disorder caused by substances produced by an underlying cancer that stimulate abnormal melanocyte growth within the eyes.

  • Underlying malignancy: Most commonly associated with cancers of the ovary, uterus, lung, pancreas, breast, or gastrointestinal tract.
  • Paraneoplastic immune response: Tumor-related factors trigger abnormal proliferation of melanocytes in the uveal tract.
  • Cultured melanocyte elongation and proliferation (CMEP) factor: A circulating serum factor has been implicated in stimulating melanocyte growth.
  • Autoimmune mechanisms: Abnormal immune responses associated with cancer may contribute to retinal and uveal changes.

When Should You See a Doctor for Bilateral Diffuse Uveal Melanocytic Proliferation (BDUMP)?

Consult an ophthalmologist promptly if you experience unexplained visual changes, especially if you have a history of cancer or are undergoing cancer treatment.

You should see a doctor if you have:

  • Gradually worsening vision in one or both eyes.
  • Distorted vision or blind spots.
  • Increasing sensitivity to light.
  • Rapid cataract development or unexplained visual decline.

Seek immediate medical attention if:

  • You experience sudden vision loss.
  • You notice flashes of light, numerous floaters, or a curtain-like shadow across your vision.
  • You develop severe eye pain or symptoms suggestive of retinal detachment.

Find Ophthalmologists for Bilateral Diffuse Uveal Melanocytic Proliferation Bdump Treatment Near You


How Is Bilateral Diffuse Uveal Melanocytic Proliferation (BDUMP) Diagnosed?

Diagnosis requires detailed ophthalmic evaluation together with investigations to identify the underlying malignancy.

  • Medical history: Reviews visual symptoms, previous cancer diagnoses, and systemic symptoms.
  • Comprehensive eye examination: Evaluates visual acuity, retinal abnormalities, cataracts, and uveal changes.
  • Fundus examination: Detects multiple reddish patches, retinal pigment epithelial abnormalities, and diffuse uveal thickening.
  • Optical coherence tomography (OCT): Assesses retinal structure and detects subretinal fluid or retinal pigment epithelium changes.
  • Fluorescein angiography: Identifies characteristic areas of retinal pigment epithelial damage.
  • Ultrasound of the eye: Evaluates diffuse thickening of the uveal tract.
  • Systemic cancer evaluation: CT scans, MRI, PET scans, tumor markers, and biopsy may be performed to identify the underlying malignancy responsible for the paraneoplastic syndrome.

What Are the Treatment Options for Bilateral Diffuse Uveal Melanocytic Proliferation (BDUMP)?

Treatment for Bilateral Diffuse Uveal Melanocytic Proliferation (BDUMP) focuses on managing the underlying cancer and preserving vision. Because BDUMP is a paraneoplastic syndrome, treating the associated malignancy is the most important step.

  • Treatment of the underlying cancer: Surgery, chemotherapy, targeted therapy, immunotherapy, or radiation therapy may help control both the malignancy and the associated eye condition.
  • Plasmapheresis: Therapeutic plasma exchange may remove circulating factors that stimulate abnormal melanocyte proliferation and improve vision in selected patients.
  • Corticosteroids: Oral or intravenous corticosteroids may be used in some cases to reduce inflammation, although the response is often limited.
  • Management of cataracts: Cataract surgery may improve vision if significant lens clouding develops.
  • Low-vision rehabilitation: Visual aids and rehabilitation services help maximize remaining vision and improve daily functioning.
  • Regular ophthalmic follow-up: Frequent eye examinations are necessary to monitor disease progression and treatment response.

Your health is everything - prioritize your well-being today.

schedule appointment Consult Bilateral Diffuse Uveal Melanocytic Proliferation Bdump Doctors Today

What Are the Complications of Bilateral Diffuse Uveal Melanocytic Proliferation (BDUMP)?

BDUMP is a progressive condition that can lead to significant visual impairment if left untreated. The prognosis is also influenced by the severity of the associated underlying cancer.

  • Progressive vision loss: Gradual deterioration of vision in both eyes is the most common complication.
  • Retinal detachment: Accumulation of subretinal fluid may cause serous retinal detachment.
  • Rapid cataract formation: Cataracts may develop quickly and further reduce vision.
  • Permanent visual impairment: Extensive retinal and uveal damage may result in irreversible vision loss.
  • Delayed cancer diagnosis: If BDUMP is not recognized as a paraneoplastic syndrome, diagnosis of the underlying malignancy may be delayed.
  • Poor overall prognosis: Since BDUMP is often associated with advanced malignancy, overall survival depends largely on the underlying cancer.

Can Bilateral Diffuse Uveal Melanocytic Proliferation (BDUMP) Be Prevented?

There is no known way to prevent BDUMP. Early detection of both visual symptoms and the underlying malignancy can improve management and reduce complications.

  • Seek prompt ophthalmic evaluation for unexplained vision changes.
  • Attend regular cancer screenings appropriate for your age and risk factors.
  • Follow recommended treatment plans if diagnosed with cancer.
  • Maintain regular follow-up with both your oncologist and ophthalmologist.

What Is the Recovery Process for Bilateral Diffuse Uveal Melanocytic Proliferation (BDUMP)?

Recovery depends on successful treatment of the underlying malignancy and the extent of eye involvement. Some patients experience stabilization or partial improvement in vision, while others may have permanent visual impairment.

  • Complete treatment for the underlying cancer as recommended by your oncology team.
  • Attend regular eye examinations to monitor retinal health and visual function.
  • Use prescribed medications and follow all postoperative instructions if cataract surgery or other procedures are performed.
  • Participate in low-vision rehabilitation if permanent vision loss occurs.
  • Maintain follow-up appointments with both ophthalmology and oncology specialists.
  • Seek immediate medical attention if you notice sudden vision loss, increasing floaters, flashes of light, severe eye pain, or symptoms suggesting retinal detachment.

Frequently Asked Questions

1. What early signs should I look for with bilateral diffuse uveal melanocytic proliferation (BDUMP)?

Look for visual disturbances like blurriness or floaters and changes in eye color. Consulting an eye specialist is important for proper diagnosis.

2. What precautions should be taken for bilateral diffuse uveal melanocytic proliferation (BDUMP)?

Regular eye exams and monitoring for vision changes are crucial for managing BDUMP.

3. Are there any risks associated with untreated bilateral diffuse uveal melanocytic proliferation (BDUMP)?

Yes, untreated BDUMP can lead to vision loss and potential complications like glaucoma or cataracts. Early detection is important for better outcomes.

4. What treatment options are available for bilateral diffuse uveal melanocytic proliferation (BDUMP)?

Treatment options for BDUMP include systemic corticosteroids, chemotherapy, immunosuppressive therapy, and radiation therapy to manage symptoms.

5. Can bilateral diffuse uveal melanocytic proliferation (BDUMP) return even after successful treatment?

Yes, BDUMP can recur even after successful treatment. Regular follow-ups are important for monitoring and early detection of recurrence.

Get A Call From Our Experts

Get A Call From Our Experts

Select a country first
Read this page in:
Book Appointment Book Appointment Second Opinion Second Opinion WhatsApp WhatsApp Find Doctors Find Doctors
Medicover Hospitals India Logo